期刊文献+

骨桥蛋白反义核苷酸对大鼠血管平滑肌细胞增殖的影响 被引量:2

Effect of osteopontin antisense nucleotide on proliferation of rat vascular smooth muscle cells
下载PDF
导出
摘要 背景:骨桥蛋白在血管损伤后新生内膜中的表达明显上调,而且能促进血管平滑肌细胞和外膜细胞的增殖、迁移。目的:探索骨桥蛋白反义核苷酸对大鼠血管平滑肌细胞增殖的影响。方法:培养大鼠A10主动脉血管平滑肌细胞,通过MTT比色法测定骨桥蛋白反义核苷酸对平滑肌细胞增殖的影响,流式细胞仪测定骨桥蛋白反义核苷酸对平滑肌细胞周期分布的影响;通过RT-PCR方法检测血管平滑肌细胞转染骨桥蛋白反义核苷酸对增殖细胞核抗原表达的影响。结果与结论:骨桥蛋白反义核苷酸对血管平滑肌细胞的增殖有明显的抑制作用,随时间延长对细胞增殖抑制率下降。骨桥蛋白反义核苷酸主要作用于G1/S限制点,能阻止血管平滑肌细胞由G0/G1期向S期推进,从而将血管平滑肌细胞阻滞于G0/G1期,抑制血管平滑肌细胞的增殖。血管平滑肌细胞转染骨桥蛋白反义核苷酸后,增殖细胞核抗原的表达水平均较对照组降低(P<0.05)?因此,得出骨桥蛋白反义核苷酸通过阻止血管平滑肌细胞由G0/G1期向S期推进,从而抑制血管平滑肌细胞的增殖,进而抑制血管内膜增生。 BACKGROUND: The expression of osteopontin (OPN) is obviously up-regulated in neointimal formation after vessel damage and promotes the proliferation and migration of vascular smooth muscle cells (VSMCs) and adventitial cells. OBJECTIVE: To explore the effect of OPN antisense nucleotide on proliferation of rat vascular smooth muscle cells. METHODS: A10 aortic VSMCs of rat were cultured. The effects of OPN antisense nucleotide on proliferation of VSMCs were observed by MTT colorimetric assay. Flow cytometry was performed to track cell cycle progression. RT-PCR was done to detect the effect of VSMCs transfected OPN antisense nucleotide on the antigen expression of proliferated cells. RESULTS AND CONCLUSION: OPN antisense nucleotide significantly inhibited VSMCs proliferation, but the inhibitory rate was decreased with time prolonged. OPN antisense nucleotide blocked VSMCs cycle in G0/G1 phase, and inhibited the proliferation of VSMCs. Compared with the control group, the antigen expression of proliferated cells were decreased obviously in the OPN antisense nucleotide group (P 0.05). Accordingly, OPN antisense nucleotide can block VSMCs cycle in G0/G1 phase, thus, inhibits the proliferation of VSMCs and suppresses the vascular intima hyperplasia.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2010年第20期3646-3649,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
基金 国家自然科学基金资助项目(30871074) 课题名称"Egr-1与骨桥蛋白相互调控机制及在血管再狭窄中的作用"~~
  • 相关文献

参考文献2

二级参考文献9

  • 1Shi Y, O' Brien JE, Fard A, et al. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation. 1996.94 : 1655-1664.
  • 2Liaw L,Skinner MP,Baines EW,et al. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins.Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest,1995,95: 713-724.
  • 3Liaw L,M Almeida,W Downey,et al. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cell in vitro. Circ Res,1994,74: 214-224.
  • 4Sambrook, EF Fritsch, T Maniatls. Molecular cloning :a laboratory manual (2nd Ed) :Cold Spring Harbor laboratory Press. 1992,367-377.
  • 5Shanahan CM, Weissberg PL, Metcalfe J C. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res,1993.73 : 193-204.
  • 6Panda D, Kundu C,C, Lee BI, et al. Potential roles of osteopontin and alphaV beta3 integrin in the development of coronary artery restenosis after angioplasty. Proc Natl Acad Sci, 1997,94: 9308-9313.
  • 7Schurch W, Seemayer TA, Gabbiani G. The myofibmblast: a quaqter century after its discovery. Am J Surg Pathol. 1998.22: 141-147.
  • 8Zohar R,Suzuki N, Suzuki K, et al. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol,2000,184: 118-130.
  • 9高平进,赵涵芳,陈玉英,易静,朱鼎良.蛋白激酶Cα参与转化生长因子诱导的血管外膜成纤维细胞转化[J].中华医学杂志,1999,79(10):784-785. 被引量:10

共引文献23

同被引文献25

  • 1刘启功,陆再英,周洪莲,张卫东,颜进.血管内皮生长因子预防血管成形术后再狭窄的机理[J].中国动脉硬化杂志,2001,9(3):209-212. 被引量:16
  • 2傅国香,朱鼎良,刘建军,高平进.骨桥蛋白参与血管紧张素Ⅱ诱导的血管平滑肌细胞迁移[J].高血压杂志,2006,14(4):277-280. 被引量:13
  • 3王旭开,王燕,杨成明,付春江,张晔,何作云.调控胰岛素致自发性高血压大鼠VSMC增殖的蛋白[J].中国病理生理杂志,2006,22(6):1061-1065. 被引量:6
  • 4方欣,管思明.骨桥蛋白与高血压血管重构[J].心脏杂志,2007,19(2):232-233. 被引量:7
  • 5Moses JW,Leon MB,Popma JJ,et al.Sirolimus-eluting stents versusstandard stents in patients with stenosis in a native coronary artery[J].NEngl J Med,2003;349(14):1315-23.
  • 6Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of asirolimus-eluting stent with a standard stent for coronary revascularization[J].N Engl J Med,2002;346(23): 1773-80.
  • 7Khachigian LM.DNAzymes:cutting a path to a class of therapeutics[J].Curr Opin Mol Ther,2002;4(2):119-21.
  • 8Lowe HC,Fahmy RG,Kavur MM,et al.Catalytic oligodeoxynucleotidesdefine a key regulatory role for early growth response factor-1 in porcinecoronary in-stent restenosis[J]? Circ Res,2001,89(10):670-7.
  • 9Gary KO,Meena K,Brian W.Molecular regulation of vascular smoothmuscle cell differentiation in development and disease[ J].Physiol Rev,2004;84:767-801.
  • 10Liu QF, Yu HW,Liu GN.Egr-1 upregulates OPN through direct bindingto its promoter and OPN upregulates Egr-1 via the ERK pathway[J].Molecul Cellular Biochem,2009; 332:77-84.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部